Below is a rank of the top 15 pharmacies that generated the most revenue from dispensing specialty pharmaceuticals in 2018, according to the Drug Channels Institute.
1. CVS Specialty/ Aetna Specialty Pharmacy — $37 billion
2. Accredo/ Freedom Fertility/ Cigna Specialty Pharmacy — $30.7 billion
3. Alliance Rx Walgreens Prime / Walgreens stores — $19.6 billion
4. BriovaRx (owned by UnitedHealth Group’s OptumRx) — $16.8 billion
5. Diplomat Pharmacy — $4.8 billion
6. Humana Specialty Pharmacy — $3.2 billion
7. Kroger Specialty Pharmacy / Kroger stores — $2.8 billion
8. Specialty Pharmacy Solutions (owned by McKesson) — $1.6 billion
9. U.S. Bioservices (owned by AmerisourceBergen) — $1.4 billion
10. Walmart Specialty Pharmacy — $1 billion
11. SenderraRx — $800 million
12. PANTHERx —$700 million
13. BioPlus Specialty Pharmacy Services — $700 million
14. Onco360/ CareMed — $600 million
15. Amber Pharmacy/ Hy-Vee Pharmacy Solutions — $500 million
More articles on pharmacy:
Judge blocks HHS rule requiring drug prices in TV ads
Nation’s 1st prescription drug affordability board goes into effect
11 healthcare pharma leaders offer advice on controlling drug spend
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
